Evidence map›Paper›PMID 27446014›Full record

ArticleFrontiers in microbiology2016

Liposome-Mediated Herpes Simplex Virus Uptake Is Glycoprotein-D Receptor-Independent but Requires Heparan Sulfate.

Lorrie A Burnham, Dinesh Jaishankar, Jeffrey M Thompson, Kevin S Jones, Deepak Shukla, Vaibhav Tiwari

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Lorrie A BurnhamDepartment of Biology, California State University San Bernardino, CA, USA.
Dinesh JaishankarDepartments of Ophthalmology and Visual Sciences, Bioengineering and Microbiology/Immunology, University of Illinois Chicago, IL, USA.
Jeffrey M ThompsonDepartment of Biology, California State University San Bernardino, CA, USA.
Kevin S JonesDepartment of Biology, Howard University Washington, DC, USA.
Deepak ShuklaDepartments of Ophthalmology and Visual Sciences, Bioengineering and Microbiology/Immunology, University of Illinois Chicago, IL, USA.
Vaibhav TiwariDepartment of Microbiology and Immunology, Midwestern University Downers Grove, IL, USA.
California State University, San Bernardino · USHoward University · USMidwestern University · USUniversity of Illinois Chicago · USUniversity of Illinois Urbana-Champaign · US

Funding

Novel Peptides Against Modified Heparan SulfateR21AI105573 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI SHUKLA, DEEPAK, TIWARI, VAIBHAV · 2014 to 2015
$440k
NIAID NIH HHS R21 AI105573
6 · The paper itself

Abstract

Cationic liposomes are widely used to facilitate introduction of genetic material into target cells during transfection. This study describes a non-receptor mediated herpes simplex virus type-1 (HSV-1) entry into the Chinese hamster ovary (CHO-K1) cells that naturally lack glycoprotein D (gD)-receptors using a commercially available cationic liposome: lipofectamine. Presence of cell surface heparan sulfate (HS) increased the levels of viral entry indicating a potential role of HS in this mode of entry. Loss of viral entry in the presence of actin de-polymerizing or lysosomotropic agents suggests that this mode of entry results in the endocytosis of the lipofectamine-virus mixture. Enhancement of HSV-1 entry by liposomes was also demonstrated in vivo using a zebrafish embryo model that showed stronger infection in the eyes and other tissues. Our study provides novel insights into gD receptor independent viral entry pathways and can guide new strategies to enhance the delivery of viral gene therapy vectors or oncolytic viruses.

Indexed as

heparan sulfateviral entryvirus-cell interactions

Identifiers

PMID27446014
PMCPMC4916164
OpenAlexW2460513961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.